Literature DB >> 21920242

Melasma: a comprehensive update: part II.

Vaneeta M Sheth1, Amit G Pandya2.   

Abstract

Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment production pathway, broad-spectrum photoprotection, and camouflage. Second-line therapy often consists of the addition of chemical peels, although these must be used cautiously in patients with darker skin. Laser and light therapies represent potentially promising options for patients who are refractory to other modalities, but also carry a significant risk of worsening the disease. A thorough understanding of the risks and benefits of various therapeutic options is crucial in selecting the best treatment.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920242     DOI: 10.1016/j.jaad.2011.06.001

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  42 in total

Review 1.  [Undesirable pigmentation].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2015-10       Impact factor: 0.751

2.  Melasma and laser treatment: an evidenced-based analysis.

Authors:  Shlomit Halachmi; Merete Haedersdal; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-06-14       Impact factor: 3.161

3.  Laser resurfacing pearls.

Authors:  Sonia Shah; Murad Alam
Journal:  Semin Plast Surg       Date:  2012-08       Impact factor: 2.314

4.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

5.  Down-regulation of tyrosinase, TRP-1, TRP-2 and MITF expressions by citrus press-cakes in murine B16 F10 melanoma.

Authors:  Sang Suk Kim; Min-Jin Kim; Young Hun Choi; Byung Kok Kim; Kwang Sik Kim; Kyung Jin Park; Suk Man Park; Nam Ho Lee; Chang-Gu Hyun
Journal:  Asian Pac J Trop Biomed       Date:  2013-08

6.  Intradermal Tranexamic Acid Injection for the Treatment of Melasma: A Pilot Study with 48-week Follow-up.

Authors:  Suparuj Lueangarun; Punyaphat Sirithanabadeekul; Prapalpitch Wongwicharn; Chutimon Namboonlue; Sarun Pacharapakornpong; Premjit Juntongjin; Therdpong Tempark
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

Review 7.  Melasma in Men: A Review of Clinical, Etiological, and Management Issues.

Authors:  Rashmi Sarkar; Pallavi Ailawadi; Shilpa Garg
Journal:  J Clin Aesthet Dermatol       Date:  2018-02-01

8.  Melasma and low-energy Q-switched laser: treatment assessment by means of in vivo confocal microscopy.

Authors:  Caterina Longo; Giovanni Pellacani; Athanasia Tourlaki; Michela Galimberti; Pier Luca Bencini
Journal:  Lasers Med Sci       Date:  2013-11-30       Impact factor: 3.161

9.  Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.

Authors:  Baishuang Yue; Qianli Yang; Jinhua Xu; Zhong Lu
Journal:  Lasers Med Sci       Date:  2016-07-23       Impact factor: 3.161

Review 10.  The Use of Natural Ingredients in the Treatment of Alopecias with an Emphasis on Central Centrifugal Cicatricial Alopecia: A Systematic Review.

Authors:  Nneamaka Ezekwe; Madelyn King; Jasmine C Hollinger
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.